Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research (2015)
- Authors:
- USP affiliated authors: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; ALVES, VENANCIO AVANCINI FERREIRA - FM ; COGLIATI, BRUNO - FMVZ
- Unidades: FM; FMVZ
- DOI: 10.1016/j.plipres.2015.05.002
- Subjects: FÍGADO GORDUROSO; BIOMARCADORES; MODELOS ANIMAIS DE DOENÇAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Progress in Lipid Research
- ISSN: 0163-7827
- Volume/Número/Paginação/Ano: v. 59, p. 106-125, July 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
WILLEBRORDS, Joost et al. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research, v. 59, p. 106-125, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.plipres.2015.05.002. Acesso em: 06 nov. 2024. -
APA
Willebrords, J., Pereira, I. V. A., Maes, M., Yanguas, S. C., Colle, I., Bossche, B. V. D., et al. (2015). Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research, 59, 106-125. doi:10.1016/j.plipres.2015.05.002 -
NLM
Willebrords J, Pereira IVA, Maes M, Yanguas SC, Colle I, Bossche BVD, Silva TC da, Oliveira CPMS de, Andraus W, Alves VAF, Cogliati B, Vinken M. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research [Internet]. Progress in Lipid Research. 2015 ; 59 106-125.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.plipres.2015.05.002 -
Vancouver
Willebrords J, Pereira IVA, Maes M, Yanguas SC, Colle I, Bossche BVD, Silva TC da, Oliveira CPMS de, Andraus W, Alves VAF, Cogliati B, Vinken M. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research [Internet]. Progress in Lipid Research. 2015 ; 59 106-125.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.plipres.2015.05.002 - Experimental models of liver fibrosis
- Quantification of experimental liver fibrosis with a novel algorithm method based on statistical analysis of signals
- Esteato-hepatite não alcoólica e doença hepática alcoólica
- 18F-FDG PET/CT as an assessment tool of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease development in experimental model
- Ultrasonographic elastography improves early detection of hepatocellular carcinoma in an experimental model of non-alcoholic steatohepatitis
- Doppler assessment of hepatic veins in obese dogs with fatty liver disease and comparison with a rodent model
- Compensated versus decompensated advanced HCV-related chronic liver disease: a morphologic and morphometric autopsy study
- Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial
- P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC
- S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
Informações sobre o DOI: 10.1016/j.plipres.2015.05.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
